Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Beijing's Bioyong Forms $38 Million IVD Collaboration with Biodesix

publication date: Jan 12, 2017
Beijing's Bioyong Technology will collaborate with Biodesix of Boulder, Colorado to bring Biodesix's VeriStrat® proteomic IVD to China. Using a blood sample, the VeriStrat test provides a prognosis for patients with non-small cell lung cancer, predicting the aggressiveness of the disease based on the host's response to the tumor. Biodesix will receive about $38 million over the course of the collaboration. The two companies may also develop additional oncology tests and expand the use of VeriStrat into other Asia-Pacific countries. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital